Are serum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), or cancer antigen 125 (CA125) associated with outcomes in patients with appendiceal adenocarcinoma? This evidence concerns the gene CEACAM5 and neoplasm.